JasonChiangMDPhD

Pathology • Memphis, TN

Neuropathology, Anatomic Pathology, Clinical Pathology

Associate Member/Professor, St. Jude Faculty

Join to view full profile

Dr. Chiang is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Chiang's full profile

Already have an account?

Office
262 Danny Thomas Pl
Memphis, TN 38105
Phone+1 888-226-4343

Fax+1 901-595-3100

Summary

Diagnosis and classification of pediatric central nervous system neoplasms; Molecular drivers and markers of pediatric central nervous system neoplasms

Education & Training

UPMC Medical EducationFellowship, Neuropathology, 2014 - 2016
UPMC Medical EducationResidency, Pathology-Anatomic and Clinical, 2011 - 2014
Johns Hopkins University School of MedicinePost-Doctoral Fellowship, 2010 - 2011
Johns Hopkins University School of MedicinePhD, Neuroscience, 2005 - 2010
Ministry of DefenceN/A, Internal Medicine, 2003 - 2005
National Taiwan University College of MedicineClass of 2003

Certifications & Licensure

CA State Medical License 2019 - 2025
TN State Medical License 2016 - 2025
PA State Medical License 2011 - 2016
American Board of Pathology Pathology - Anatomic
American Board of Pathology Neuropathology

Awards, Honors, & Recognition

Top Downloaded Article in 2021 Brain Pathology, 2023
Top Cited Article 2021 – 2022 Brain Pathology, 2023
American Association of Neuropathologists Travel Award American Association of Neuropathologists, 2015
Pathology Postdoctoral Research Training Program Award University of Pittsburgh School of Medicine Department of Pathology, 2015
Maryland Stem Cell Research Fund Post-Doctoral Fellowship Maryland Stem Cell Research Fund, 2010
American Heart Association Predoctoral Fellowship American Heart Association, 2009
Taiwan Merit Scholarship Taiwan, 2005
Join now to see all

Clinical Trials

Risk-Adapted Therapy for Young Children With Embryonal Brain Tumors, Choroid Plexus Carcinoma, High Grade Glioma or Ependymoma Start of enrollment: 2007 Dec 17
Active, not recruiting
Phase 2
Protocol for the Study and Treatment of Participants With Intraocular Retinoblastoma Start of enrollment: 2013 Jun 19
Active, not recruiting
Phase 2
A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma Start of enrollment: 2013 Jun 23
Active, not recruiting
Phase 2
Phase 2 Study of Alisertib Therapy for Rhabdoid Tumors Start of enrollment: 2014 May 14
Active, not recruiting
Phase 2
A Trial of Surgery and Fractionated Re-Irradiation for Recurrent Ependymoma Start of enrollment: 2014 May 07
Active, not recruiting
Phase 2
Intravitreal Carboplatin for the Treatment of Participants With Recurrent or Refractory Intraocular Retinoblastoma Start of enrollment: 2016 Nov 01
Completed
Phase 1
A Phase II Trial of Intensity-Modulated Proton Therapy for Incompletely Resected Craniopharyngioma and Observation for Craniopharyngioma After Radical Resection Start of enrollment: 2016 Jun 22
Recruiting
Phase 2
Study of GDC-0084 in Pediatric Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma or Diffuse Midline Gliomas Start of enrollment: 2018 Nov 19
Completed
Phase 1
Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma Start of enrollment: 2019 Aug 28
Recruiting
Not Applicable
PDGFR Inhibitor Crenolanib in Children/Young Adults With Diffuse Intrinsic Pontine Glioma or Recurrent High-Grade Glioma Start of enrollment: 2011 Jul 01
Completed
Phase 1
SJ901: Evaluation of Mirdametinib in Children, Adolescents, and Young Adults With Low-Grade Glioma Start of enrollment: 2021 Jun 21
Recruiting
Phase 1, Phase 2
Loc3CAR: Locoregional Delivery of B7-H3-CAR T Cells for Pediatric Patients With Primary CNS Tumors Start of enrollment: 2023 Apr 27
Recruiting
Phase 1
Join now to see all

Publications & Presentations

PubMed

68 citations
Cell-surface antigen profiling of pediatric brain tumors: B7-H3 is consistently expressed and can be targeted via local or systemic CAR T-cell delivery.
Dalia Haydar, Haley Houke, Jason Chiang, Zhongzhen Yi, Zelda Odé
Neuro-Oncology. 2021-06-01
3 citations
Somatic LINE-1 promoter acquisition drives oncogenic FOXR2 activation in pediatric brain tumor.
Diane A Flasch, Xiaolong Chen, Bensheng Ju, Xiaoyu Li, James Dalton
Acta Neuropathologica. 2022-05-01
51 citations
Structure and evolution of double minutes in diagnosis and relapse brain tumors
Ke Xu, Liang Ding, Ti-Cheng Chang, Ying Shao, Jason Chiang
Acta Neuropathologica. 2019-01-01

Professional Memberships

American Association of Neuropathologists
Member

Other Languages

Chinese (Mandarin), Taiwanese, Spanish

External Links

St. Jude Children's Research Hospitalhttps://www.stjude.org/chiang